Active-ingredient Dossier
Glatiramer Acetate
Active-ingredient Dossier for Glatiramer Acetate (immunosuppressant agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: COPAXONE
- Brand: GLATIRA
- Brand: GLATIRAMER ACETATE-TEVA
- Brand: GLATIRAMER
- Brand: MULTIROS
- Therapeutic area: Neurology
What is
Glatiramer Acetate Glatiramer Acetate is an immunosuppressant agent.
Australian brands containing
Glatiramer Acetate — COPAXONE — GLATIRA — GLATIRAMER ACETATE-TEVA — GLATIRAMER — MULTIROS
Therapeutic areas
Glatiramer Acetate is registered in neurology, with 5 brands containing the ingredient.
Sponsor landscape
The ingredient is marketed by three sponsors: Teva Pharma, Juno Pharmaceuticals, and Alphapharm.
PBS and regulatory activity
One brand containing Glatiramer Acetate has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is 1 March 2021, with two brands having PBAC outcomes on record.